Estrella Immunopharma Inc.

ESLA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.53

$0 (+0.19%)

Sep 21, 2026, 12:48 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Jun 29, 2024	FY 2022 Dec 30, 2022	FY 2021 Jun 29, 2022
Cash & Equivalents	1.38M	916.92K	4.17M	40.8K	4.09M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	9.67M	45.19M
Other Long-Term Assets	1.5M	1.5M	9.93M	n/a	n/a
Receivables	n/a	n/a	288.76K	273.07K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	292.67K	723.86K	-401.25K	-273.07K	n/a
Total Current Assets	1.68M	1.64M	4.45M	52.43K	4.92M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.5M	1.5M	9.93M	9.93M	45.19M
Total Assets	3.18M	3.14M	4.45M	9.99M	4.92M
Account Payables	554.78K	n/a	77.08K	n/a	945.59K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	498.6K	n/a
Other Current Liabilities	12.93M	2.98M	52.67K	102.51K	n/a
Total Current Liabilities	13.54M	3M	180.7K	1.07M	946.68K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	1.55M	5.01M
Total Long-Term Liabilities	n/a	n/a	n/a	1.84M	5.01M
Total Liabilities	13.54M	3M	180.7K	2.92M	5.96M
Total Debt	n/a	n/a	n/a	498.6K	n/a
Book Value	-10.37M	143.73K	4.27M	7.07M	-1.04M
Book Value Per Share	-0.28	0	0.12	1.23	-0.18
Common Stock	3.85K	3.67K	3.66K	98	18
Retained Earnings	-36.99M	-23.93M	-19.5M	-2.26M	-1.07M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-10.37M	143.73K	4.27M	7.07M	-1.04M
Total Investments	n/a	n/a	n/a	9.67M	45.19M